Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. [electronic resource]
Producer: 20051102Description: 7161-7 p. digitalISSN:- 0732-183X
- Adolescent
- Age Factors
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asparaginase -- administration & dosage
- Child
- Child, Preschool
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Infant
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.